Drug Information

Drug General Information
Drug ID
D09XLZ
Former ID
DNC006087
Drug Name
4-[4-(benzoylamino)benzoyl]benzoic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527979]
Formula
C21H15NO4
Canonical SMILES
C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)C(=O)<br />O
InChI
1S/C21H15NO4/c23-19(14-6-8-17(9-7-14)21(25)26)15-10-12-18(13-11-15)22-20(24)16-4-2-1-3-5-16/h1-13H,(H,22,24)(H,25,26)
InChIKey
FKMULXSKUTZDBD-UHFFFAOYSA-N
PubChem Compound ID
11681722
Target and Pathway
Target(s) 3-oxo-5-alpha-steroid 4-dehydrogenase 2 Target Info Inhibitor [527979]
BioCyc Pathway Superpathway of steroid hormone biosynthesis
Allopregnanolone biosynthesis
Androgen biosynthesis
KEGG Pathway Steroid hormone biosynthesis
Prostate cancer
Reactome Androgen biosynthesis
References
Ref 527979J Med Chem. 2006 Jan 26;49(2):748-59.Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids.
Ref 527979J Med Chem. 2006 Jan 26;49(2):748-59.Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids.